Localization of the lipid receptors CD36 and CLA-1/SR-BI in the human gastrointestinal tract:: Towards the identification of receptors mediating the intestinal absorption of dietary lipids

被引:114
作者
Lobo, MVT
Huerta, L
Ruiz-Velasco, N
Teixeiro, E
de la Cueva, P
Celdrán, A
Martín-Hidalgo, A
Vega, MA
Bragado, R
机构
[1] Fdn Jimenez Diaz, Dept Immunol, E-28040 Madrid, Spain
[2] Hosp Ramon & Cajal, Dept Invest, E-28034 Madrid, Spain
[3] Univ Alcala de Henares, Dept Biol Celular & Genet, Madrid, Spain
[4] Hosp Ramon & Cajal, Serv Bioquim Invest, E-28034 Madrid, Spain
[5] CSIC, Madrid, Spain
[6] Fdn Jimenez Diaz, Serv Cirugia Digest, E-28040 Madrid, Spain
关键词
intestinal lipid absorption; intestinal lipid receptors; CD36; CLA-1/SR-BI;
D O I
10.1177/002215540104901007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The scavenger receptors CLA-1/SR-BI and CD36 interact with native and modified lipoproteins and with some anionic phospholipids. In addition, CD36 binds/transports long-chain free fatty acids. Recent biochemical evidences indicates that the rabbit CLA-1/SR-BI receptor can be detected in enterocytes, and previous studies showed the presence of mRNA for both CLA-1/SR-BI and CD36 in some segments of the intestinal tract. These findings prompted us to study their respective localization and distribution from the human stomach to the colorectal segments, using immunohistochemical methods. Their expression in the colorectal carcinoma-derived cell line Caco-2 was analyzed by Northern blotting. In the human intestinal tract, CLA-1/SR-BI was found in the brush-border membrane of enterocytes from the duodenum to the rectum, However, CD36 was found only in the duodenal and jejunal epithelium, whereas enterocytes from other intestinal segments were not stained. In the duodenum and jejunum, CD36 co-localized with CLA-1/SR-BI in the apical membrane of enterocytes. The gastric epithelium was immunonegative for both glycoproteins. We also found that CLA-1/SR-BI mRNA was expressed in Caco-2 cells and that its expression levels increased concomitantly with their differentiation. In contrast, the CD36 transcript was not found in this colon cell line, in agreement with the absence of this protein in colon epithelium. The specific localization of CLA-1/SR-BI and CD36 along the human gastrointestinal tract and their ability to interact with a large variety of lipids strongly support a physiological role for them in absorption of dietary lipids.
引用
收藏
页码:1253 / 1260
页数:8
相关论文
共 49 条
[31]  
Mehran M, 1997, IN VITRO CELL DEV-AN, V33, P118
[32]   Regulation of cholesterol metabolism by dietary plant sterols [J].
Miettinen, TA ;
Gylling, H .
CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (01) :9-14
[33]  
Morehouse LA, 1999, J LIPID RES, V40, P464
[34]   REDUCED UPTAKE OF OXIDIZED LOW-DENSITY LIPOPROTEINS IN MONOCYTE-DERIVED MACROPHAGES FROM CD36-DEFICIENT SUBJECTS [J].
NOZAKI, S ;
KASHIWAGI, H ;
YAMASHITA, S ;
NAKAGAWA, T ;
KOSTNER, B ;
TOMIYAMA, Y ;
NAKATA, A ;
ISHIGAMI, M ;
MIYAGAWA, JI ;
KAMEDATAKEMURA, K ;
KURATA, Y ;
MATSUZAWA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1859-1865
[35]   CD36, a member of the class B scavenger receptor family, as a receptor for advanced glycation end products [J].
Ohgami, N ;
Nagai, R ;
Ikemoto, M ;
Arai, H ;
Kuniyasu, A ;
Horiuchi, S ;
Nakayama, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (05) :3195-3202
[36]   Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine - Comparison with fatty acid-binding proteins (FABP) [J].
Poirier, H ;
Degrace, P ;
Niot, I ;
Bernard, A ;
Besnard, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 238 (02) :368-373
[37]   Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers [J].
Repa, JJ ;
Turley, SD ;
Lobaccaro, JMA ;
Medina, J ;
Li, L ;
Lustig, K ;
Shan, B ;
Heyman, RA ;
Dietschy, JM ;
Mangelsdorf, DJ .
SCIENCE, 2000, 289 (5484) :1524-1529
[38]   THE CLASS-B SCAVENGER RECEPTORS SR-BI AND CD36 ARE RECEPTORS FOR ANIONIC PHOSPHOLIPIDS [J].
RIGOTTI, A ;
ACTON, SL ;
KRIEGER, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (27) :16221-16224
[39]   HYPOCHOLESTEROLEMIC ACTIVITY OF A NOVEL INHIBITOR OF CHOLESTEROL ABSORPTION, SCH-48461 [J].
SALISBURY, BG ;
DAVIS, HR ;
BURRIER, RE ;
BURNETT, DA ;
BOYKOW, G ;
CAPLEN, MA ;
CLEMMONS, AL ;
COMPTON, DS ;
HOOS, LM ;
MCGREGOR, DG ;
SCHNITZERPOLOKOFF, R ;
SMITH, AA ;
WEIG, BC ;
ZILLI, DL ;
CLADER, JW ;
SYBERTZ, EJ .
ATHEROSCLEROSIS, 1995, 115 (01) :45-63
[40]  
Schulthess G, 1996, J LIPID RES, V37, P2405